Expansion into new geographies and enhanced approval for STIMULAN to treat bacterial infection Keele, UK, 15 December 2021 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is pleased to provide the following business update. Read more…
STIMULAN® is the first and only calcium matrix approved as an antibiotic carrier for use in bone and soft tissue • Distribution established with leader in German orthopaedic market Keele, UK, 7 December 2021 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone […]
Against the backdrop of the pandemic and Brexit, Biocomposites’ lead product STIMULAN became the first calcium matrix to receive European approval as an antibiotic carrier for use in bone and soft-tissue.
